4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-027942
SVP & Chief Financial Officer sold 90,000 shares at an average $84.05 ($7,564,200)
- SVP & Chief Financial Officer acquired 90,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Labrucherie Gil M · SVP & Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-05-01 | Exercise or conversion : show line 1 in the form | +30,000 | $10.69 | $320,700 | 129,739 | D |
| 2018-05-01 | Sale : show line 2 in the form | −30,000 | $83.65 | $2,509,500 | 99,739 | D |
| 2018-05-02 | Exercise or conversion : show line 3 in the form | +30,000 | $10.69 | $320,700 | 129,739 | D |
| 2018-05-02 | Sale : show line 4 in the form | −30,000 | $85.63 | $2,568,900 | 99,739 | D |
| 2018-05-03 | Exercise or conversion : show line 5 in the form | +30,000 | $10.69 | $320,700 | 129,739 | D |
| 2018-05-03 | Sale : show line 6 in the form | −30,000 | $82.86 | $2,485,800 | 99,739 | D |
| Open-market sales · 90,000 sh · avg $84.05 · $7,564,200 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-05-01 | Exercise or conversion : show line 7 in the form Stock Option | −30,000 | 60,000 | D |
| 2018-05-02 | Exercise or conversion : show line 8 in the form Stock Option | −30,000 | 30,000 | D |
| 2018-05-03 | Exercise or conversion : show line 9 in the form Stock Option | −30,000 | 0 | D |
Loading xslF345X03/doc4.xml…